Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9-Year Experience

Annals of Thoracic Surgery

Volumn 102, Issue 4, 2016, Pages 1266-1273

  Morgan, Jeffrey A ^a   Go, Pauline H ^a   Xuereb, Linnea ^a   Kaur, Babbaljeet ^a   Akrawe, Silvy ^a   Nemeh, Hassan W ^a   Borgi, Jamil ^a   Lanfear, David E ^a   Williams, Celeste T ^a   Paone, Gaetano ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; DEVICE INFECTION; DIABETES MELLITUS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART RIGHT VENTRICLE FAILURE; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; KIDNEY FAILURE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PATIENT HISTORY OF SURGERY; PERIPHERAL VASCULAR DISEASE; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RESPIRATORY FAILURE; SURVIVAL RATE; SURVIVAL TIME; DOPPLER ECHOCARDIOGRAPHY; EVALUATION STUDY; FACTUAL DATABASE; FOLLOW UP; HEART ASSIST DEVICE; HEART FAILURE; HEMODYNAMICS; KAPLAN MEIER METHOD; LENGTH OF STAY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; OPERATION DURATION; PHYSIOLOGIC MONITORING; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UTILIZATION;

ADULT; DATABASES, FACTUAL; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MULTIVARIATE ANALYSIS; OPERATIVE TIME; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84975167797     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2016.03.026     Document Type: Article

References (26)

1. 1 Rose, E.A., Gelijns, A.C., Moskowitz, A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345 (2001), 1435–1443.
2. 2 Frazier, O.H., Rose, E.A., Oz, M.C., et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 122 (2001), 1186–1195.
3. 3 Slaughter, M.S., Rogers, J.G., Milano, C.A., et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361 (2009), 2241–2251.
4. 4 Pagani, F.D., Miller, L.W., Russell, S.D., et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 54 (2009), 312–321.
5. 5 Miller, L.W., Pagani, F.D., Russell, S.D., et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357 (2007), 885–896.
6. 6 Tsiouris, A., Paone, G., Nemeh, H.W., et al. Lessons learned from 150 continuous flow left ventricular assist devices: a single institutional seven-year experience. ASAIO J 61 (2015), 266–273.
7. 7 Morgan, J.A., Brewer, R.J., Nemeh, H.W., et al. Management of aortic valve insufficiency in patients supported by long-term continuous flow left ventricular assist devices. Ann Thorac Surg 94 (2012), 1710–1712.
8. 8 Morgan, J.A., Brewer, R.J., Nemeh, H.W., et al. Stroke while on long-term left ventricular assist device support: incidence, outcome, and predictors. ASAIO J 60 (2014), 284–289.
9. 9 Tsiouris, A., Morgan, J.A., Nemeh, H.W., et al. Does elective or urgent/emergent operative status influence outcomes in patients undergoing implantation of left ventricular assist devices?. Heart Surg Forum 17 (2014), E64–E72.
10. 10 Morgan, J.A., Nemeh, H.N., Paone, G., Should left ventricular assist devices be implanted in patients over seventy years of age and older: a comparable analysis. Heart Surg Forum 17 (2014), E182–E186.
11. 11 Aaronson, K.D., Slaughter, M.S., Miller, L.W., et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 125 (2012), 3191–3200.
12. 12 Morgan, J.A., Brewer, R.J., Nemeh, H.W., et al. Left ventricular reverse remodeling with a continuous flow lvad as measured by left ventricular end diastolic dimensions and severity of mitral regurgitation. ASAIO J 58 (2012), 574–577.
13. 13 Tsiouris, A., Brewer, R.J., Borgi, J., et al. Ischemic versus nonischemic cardiomyopathy: the implication of heart failure etiology on left ventricular assist device outcomes. ASAIO J 59 (2013), 130–135.
14. 14 Morgan, J.A., Paone, G., Nemeh, H.W., et al. Impact of continuous-flow left ventricular assist device support on right ventricular function. J Heart Lung Transplant 32 (2013), 398–403.
15. 15 Borgi, J., Tsiouris, A., Hodari, A., Cogan, C.M., Paone, G., Morgan, J.A., Significance of postoperative acute renal failure after continuous-flow left ventricular assist device implantation. Ann Thorac Surg 95 (2013), 163–169.
16. 16 Morgan, J.A., Paone, G., Nemeh, H.W., et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device. J Heart Lung Transplant 31 (2012), 715–718.
17. 17 Tsiouris, A., Morgan, J.A., Nemeh, H.W., Hodari, A., Brewer, R.J., Paone, G., Sex-specific outcomes in patients receiving continuous-flow left ventricular devices as a bridge to transplantation or destination therapy. ASAIO J 60 (2014), 199–206.
18. 18 Crow, S., Chen, D., Milano, C., et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg 90 (2010), 1263–1269 discussion 1269.
19. 19 MacGowan, G.A., Schueler, S., Right heart failure after left ventricular assist device implantation: early and late. Curr Opin Cardiol 27 (2012), 296–300.
20. 20 Ochiai, Y., McCarthy, P.M., Smedira, N.H., et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 106:12 Suppl 1 (2002), I198–I202.
21. 21 Mathews, J.C., Koelling, T.M., Pagani, F.D., Aaronson, K.D., The right ventricular failure risk score: a preoperative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 51 (2008), 2163–2172.
22. 22 John, R., Kamdar, F., Liao, K., Colvin-Adams, M., Boyle, A., Joyce, L., Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 86 (2008), 1227–1234 discussion 1234–5.
23. 23 Kato, T.S., Schulze, P.C., Yang, J., et al. Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. J Heart Lung Transplant 31 (2012), 1–8.
24. 24 Forest, S.J., Bello, R., Friedmann, P., et al. Readmissions after ventricular assist device: etiologies, patterns, and days out of hospital. Ann Thorac Surg 95 (2013), 1276–1281.
25. 25 Hasin, T., Marmor, Y., Kremers, W., et al. Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol 61 (2013), 153–163.
26. 26 Tsiouris, A., Paone, G., Nemeh, H.W., Brewer, R.J., Morgan, J.A., Factors determining post-operative readmissions after left ventricular assist device implantation. J Heart Lung Transplant 33 (2014), 1141–1147.